Search

Your search keyword '"Jones, C. Michael"' showing total 149 results

Search Constraints

Start Over You searched for: Author "Jones, C. Michael" Remove constraint Author: "Jones, C. Michael" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
149 results on '"Jones, C. Michael"'

Search Results

2. Method of targeted delivery of laser beam to isolated retinal rods by fiber optics

3. Measurement of Photon Statistics with Live Photoreceptor Cells

4. Smoking History Predicts Sensitivity to PARP Inhibitor Veliparib in Patients with Advanced Non–Small Cell Lung Cancer

5. Supplemental Materials from Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer

8. Sustained interactive Wnt and FGF signaling is required to maintain isthmic identity

9. The NLRR gene family and mouse development: modified differential display PCR identifies NLRR-1 as a gene expressed in early somitic myoblasts

17. Embryonic expression of Lim-1, the mouse homolog of Xenopus XLim-1, suggests a role in lateral mesoderm differentiation and neurogenesis

18. Neural tube derived Wnt signals cooperate with FGF signaling in the formation and differentiation of the trigeminal placodes

19. Transcriptional Regulation of Hhex in Hematopoiesis and Hematopoietic Stem Cell Ontogeny

20. Randomized, Placebo-Controlled, Phase II Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non–Small Cell Lung Cancer

23. A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial

25. Smoking status to predict sensitivity to PARP inhibitor, veliparib, in patients with advanced NSCLC.

35. FGFR1 Signaling Stimulates Proliferation of Human Mesenchymal Stem Cells by Inhibiting the Cyclin-Dependent Kinase Inhibitors p21Waf1 and p27Kip1

40. WLS-dependent secretion of WNT3A requires Ser209 acylation and vacuolar acidification

41. Functional Coupling between the Extracellular Matrix and Nuclear Lamina by Wnt Signaling in Progeria

Catalog

Books, media, physical & digital resources